Totaligent
Boca Raton, Florida, United States · Advertising, Analytics, Artificial Intelligence
Totaligent, Inc. is a cutting-edge AI-powered digital marketing platform that revolutionizes audience targeting, engagement, and conversion. By leveraging advanced artificial intelligence, big data analytics, and real-time consumer insights, Totaligent empowers businesses to execute highly precise, fraud-free marketing campaigns. Its platform seamlessly integrates Email, SMS, Social Media, Data Ap
Key facts
- Headquarters
- Boca Raton, Florida, United States
- Employees
- Unknown
- Industries
- Advertising, Analytics, Artificial Intelligence
- Status
- Public (TGNT)
- Website
- totaligent.com
- Company page
Recent activity at Totaligent
- : SEC 8-K (1.01):
- : SEC 8-K (1.01): On March 22, 2026, Totaligent, Inc. entered into an Extension Amendment to the Binding Letter of Intent with GloMed Solutions LLC, which originally dated February 22, 2026. This Amendment extends the negotiation and execution deadlines for definitive agreements concerning a proposed joint venture and a call option for Totaligent to acquire GloMed's business, intellectual property, and related assets. The new target date for closing the transaction and completing negotiations is now set for April 22, 2026. This extension allows both parties additional time for thorough discussions and due diligence, with all other terms of the original LOI remaining in effect.
- : SEC 8-K (1.01):
- : SEC 8-K (1.01): On March 4, 2026, Totaligent, Inc. entered into an Extension Amendment to the Binding Letter of Intent with Aetherium Medical. The Amendment extends the negotiation and execution timeline for definitive agreements related to a proposed acqui-hire transaction, in which Totaligent would acquire Aetherium's team, business plan, and associated assets in exchange for equity. The target closing date has been pushed from March 5, 2026, to March 20, 2026, permitting additional time for due diligence. The exclusivity period remains intact through April 5, 2026, and all other terms of the LOI are unaffected by this Amendment.
- : SEC 8-K (1.01): On February 22, 2026, Totaligent, Inc. entered into a Binding Letter of Intent with GloMed Solutions LLC to establish a joint venture that will integrate the Aetherium Medical platform with GloMed's operations. GloMed, which generates approximately $10 million in annual revenue, will contribute its infrastructure and expertise, while Totaligent provides the Aetherium Medical platform and related assets. The joint venture is expected to commence operations four weeks after the LOI, with a target closing date around March 22, 2026. GloMed will retain baseline income, with all additional revenue from the JV to be shared, and Totaligent has a call option to acquire GloMed within a year for $3,000,000 plus 15% equity in Totaligent. The agreement includes various binding provisions and is subject to due diligence and execution of definitive agreements.
- : SEC 8-K (1.01): On February 11, 2026, Totaligent, Inc. entered into a Binding Letter of Intent (LOI) with Aetherium Medical to propose an acqui-hire transaction, through which Totaligent will acquire Aetherium's team, business plan, intellectual property, and assets in exchange for equity in Totaligent. As part of this agreement, a new subsidiary, Aetherium Medical LLC, will be created, and Ivan Klarich, Aetherium’s CEO, will be appointed as Managing Director. The deal includes the issuance of 10% of Totaligent's outstanding common stock to Mr. Klarich and Aetherium's key team members, subject to performance-based vesting. The target closing date for the definitive agreements is March 5, 2026, with binding provisions on exclusivity and confidentiality included in the LOI.
- : SEC 8-K (1.01): On February 11, 2026, Totaligent, Inc. entered into a Binding Letter of Intent (LOI) with Aetherium Medical, proposing an acqui-hire transaction. This agreement involves the acquisition of Aetherium's team, business plan, intellectual property, know-how, contacts, and related assets in exchange for equity in Totaligent, with no cash consideration at closing. Aetherium Medical LLC will be formed as a wholly owned subsidiary to receive these assets, and Ivan Klarich, the CEO of Aetherium, will be appointed as Managing Director of the new subsidiary. Furthermore, 10% of Totaligent's outstanding common stock will be issued to Klarich and key members of Aetherium's team, subject to performance-based vesting and other customary terms.
- : Totaligent, Inc. launches a beta website for its AI-powered marketing platform designed to enhance audience engagement for businesses.
- : ALLTEMP, INC.
Totaligent funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2018 | Seed | $350K |
Leadership
- Kiell Nesen, Executive Officer, Director
- William Lopshire, Executive Officer, Director
- Brian Heckathorne, Chief Technology Officer
Verified email and direct lines for Totaligent’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Totaligent in the news
Companies similar to Totaligent
- Mapp · Advertising, Analytics, Artificial Intelligence, Machine Learning, Marketing, Marketing Automation, SaaS, Software
- Recast · Advertising, Analytics, Artificial Intelligence, Machine Learning, Marketing, Marketing Automation, SaaS, Software
- SOCi · Advertising, Analytics, Artificial Intelligence, Machine Learning, Marketing, Marketing Automation, SaaS, Software
- Phave · Advertising, Analytics, Artificial Intelligence, Machine Learning, Marketing, Marketing Automation, SaaS, Software
- Bluefish · Advertising, Analytics, Artificial Intelligence, Machine Learning, Marketing, Marketing Automation, SaaS, Software
About Totaligent: questions and answers
What does Totaligent do?
Totaligent, Inc. is a cutting-edge AI-powered digital marketing platform that revolutionizes audience targeting, engagement, and conversion. By leveraging advanced artificial intelligence, big data analytics, and real-time consumer insights, Totaligent empowers businesses to execute highly precise, fraud-free marketing campaigns. Its platform seamlessly integrates Email, SMS, Social Media, Data Ap
Where is Totaligent headquartered?
Totaligent is headquartered in Boca Raton, Florida, United States.
Has Totaligent raised funding?
Yes. Fundz has recorded 1 funding event for Totaligent. The most recent, Seed of $350K, was in Aug 2018.
What is the latest news on Totaligent?
On Apr 15, 2026, SEC 8-K (1.01):
Is Totaligent a public company?
Yes. Totaligent is publicly traded under the ticker TGNT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy